GNTA
Genenta Science·NASDAQ
--
--(--)
--
--(--)
0.97 / 10
Underperform
Genenta Science's fundamentals are rated underperform with a 1.0/10 score. Key weaknesses include a zero net-profit-to-total-profit ratio and gross-profit margin, while current and fixed assets turnover ratios are mixed. Historical back-tests show negative one-month returns for most metrics, reinforcing the cautionary stance on the company's operational efficiency and profitability.
Analysis Checks(3/5)
Inventory turnover ratio
Value37.99
Score2/3
Weight191.46%
1M Return-2.63%
Value37.99
Score2/3
Weight191.46%
1M Return-2.63%
Current assets turnover ratio
Value1.17
Score2/3
Weight-88.34%
1M Return1.15%
Value1.17
Score2/3
Weight-88.34%
1M Return1.15%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight22.32%
1M Return-0.30%
Value100.00
Score0/3
Weight22.32%
1M Return-0.30%
Gross profit margin (%)
Value38.10
Score1/3
Weight38.92%
1M Return-0.54%
Value38.10
Score1/3
Weight38.92%
1M Return-0.54%
Fixed assets turnover ratio
Value1031.01
Score3/3
Weight-64.36%
1M Return0.86%
Value1031.01
Score3/3
Weight-64.36%
1M Return0.86%
Inventory turnover ratio
Value37.99
Score2/3
Weight191.46%
1M Return-2.63%
Value37.99
Score2/3
Weight191.46%
1M Return-2.63%
Gross profit margin (%)
Value38.10
Score1/3
Weight38.92%
1M Return-0.54%
Value38.10
Score1/3
Weight38.92%
1M Return-0.54%
Current assets turnover ratio
Value1.17
Score2/3
Weight-88.34%
1M Return1.15%
Value1.17
Score2/3
Weight-88.34%
1M Return1.15%
Fixed assets turnover ratio
Value1031.01
Score3/3
Weight-64.36%
1M Return0.86%
Value1031.01
Score3/3
Weight-64.36%
1M Return0.86%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight22.32%
1M Return-0.30%
Value100.00
Score0/3
Weight22.32%
1M Return-0.30%
Is GNTA undervalued or overvalued?
- GNTA scores 0.97/10 on fundamentals and holds a Premium valuation at present. Backed by its -31.10% ROE, 0.00% net margin, -1.82 P/E ratio, 1.20 P/B ratio, and 6.04% earnings growth, these metrics solidify its Underperform investment rating.
